SearchDictionaryMobileLogin

Urinary Diversion (Ileal Conduit)

1549  relevant articles (57 outcomes, 60 trials/studies) found for this Therapy

Description: Temporary or permanent diversion of the flow of urine through the ureter away from the URINARY BLADDER in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. (From Campbell's Urology, 6th ed, p2654)

Also Known As:
Ileal Conduit; Urinary Diversions; Conduit, Ileal; Conduits, Ileal; Diversion, Urinary; Diversions, Urinary; Ileal Conduits

Relationship Network

Therapy Context: Research Results

Experts

1. Stein, John P: 4 articles (04/2008 - 04/2005)
2. Penson, David F: 3 articles (09/2007 - 04/2005)
3. Schwarz, Manfred: 3 articles (07/2005 - 07/2005)
4. Thüroff, Joachim W: 3 articles (07/2005 - 07/2005)
5. Wiesner, Christoph: 3 articles (07/2005 - 07/2005)
6. Beetz, Rolf: 3 articles (07/2005 - 07/2005)
7. Stein, Raimund: 3 articles (07/2005 - 07/2005)
8. Smith, Joseph A: 3 articles (11/2003 - 04/2003)
9. Stenzl, Arnulf: 2 articles (05/2008 - 03/2007)
10. Pruthi, Raj S: 2 articles (09/2007 - 09/2007)

Related Diseases

1. Urinary Bladder Neoplasms (Bladder Cancer)
09/01/2000 - "Even though radical cystectomy still remains the 'gold standard' for the treatment of invasive bladder cancer, newer insights and developments are entering the urological arena: a 'tailored' surgical approach combining a less extensive procedure and a better quality of life seems feasible for selected patients without compromising the outcome; the type of urinary diversion has no impact on the risk of complications, the ability to receive postoperative salvage treatments and the natural history of the disease; the depth of extension of the tumour and the nodal involvement are the only independent 'classical' predictors of survival after radical cystectomy; pelvic node dissection is curative in patients with limited nodal involvement; the clinical application of newer molecular prognostic factors still remains controversial."
07/01/2006 - "With the provision of a functionally adequate urinary diversion, cystectomy represents an effective treatment for patients with muscle-invasive bladder cancer without metastatic spread"
07/01/2008 - "CONCLUSION: LRC or RRC with extracorporeally constructed urinary diversion is a safe and effective operation for appropriate patients with bladder cancer"
03/01/1995 - "This new type of urinary diversion with improved body image can be offered to female patients undergoing cystectomy for bladder cancer."
08/01/2007 - "BACKGROUND: Radical cystectomy with urinary diversion is the current gold standard procedure for muscle-invasive bladder cancer"
Order ALL the reference details at left...
2. Neoplasms (Cancer)
3. Calculi (Calculus)
4. Neurogenic Urinary Bladder (Bladder, Neurogenic)
5. Fistula

Related Drugs and Biologics

1. Gelatin
2. Flucytosine (Ancobon)
3. Citrates
4. Amphotericin B (Amphotericin)
5. nuclear matrix protein 22
6. aluminum sulfate (alum)
7. Metoclopramide (Reglan)
8. Immunoglobulin G (IgG)
9. Calcium Oxalate
10. Phenobarbital (Luminal)

Related Therapies and Procedures

1. Cystectomy
2. Urinary Diversion (Ileal Conduit)
3. Stents
4. Lithotripsy (Extracorporeal Shockwave Lithotripsy)
5. Transplants (Transplant)

Best Treatments:
Research Summary Report
on Urinary Bladder Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 584 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>